Probing the human hippocampus using rCBF: Contrasts in schizophrenia

Hippocampus

Volumn 11, Issue 5, 2001, Pages 543-550

  Medoff, Deborah R ^a   Holcomb, Henry H ^a   Lahti, Adrienne C ^a   Tamminga, Carol A ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Auditory discrimination; Hippocampus; Ketamine; rCBF; Schizophrenia

Indexed keywords

HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PLACEBO; RECEPTOR SUBUNIT;

ADULT; ARTICLE; AUDITORY DISCRIMINATION; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; DISEASE ASSOCIATION; DRUG POTENCY; EVALUATION; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; LEARNING; MALE; NUCLEAR MAGNETIC RESONANCE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; REST; SCHIZOPHRENIA; TASK PERFORMANCE; VOLUMETRY; VOLUNTEER;

ACOUSTIC STIMULATION; ADULT; ANTIPSYCHOTIC AGENTS; CEREBROVASCULAR CIRCULATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HALOPERIDOL; HIPPOCAMPUS; HUMANS; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; PITCH DISCRIMINATION; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035189584     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/hipo.1070     Document Type: Article

References (65)

1. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development
2. Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection
3. Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia
4. Reduced neuronal size in posterior hippocampus of schizophrenic patients
5. Deficits in small interneurons in prefrontal and cingulate cortex of schizophrenic and schizoaffective patients
6. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics
7. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
8. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain
9. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia
10. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage
11. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia
12. The parahippocampal region: Corticocortical connectivity
13. Perirhinal and postrhinal cortices of the rat: A review of the neuroanatomical literature and comparison with findings from the monkey brain [published erratum appears in Hippocampus 1996;6:340]
14. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain
15. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
16. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice
17. Schizophrenia
18. Physiological patterns in the hippocampo-entorhinal cortex system
19. Hippocampal morphometry in schizophrenia by high dimensional brain mapping
20. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia
21. The missing link: A failure of fronto-hippocampal integration in schizophrenia
22. Plastic transformation of PET images
23. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: Effects of schizophrenia
24. Gating of information flow within the limbic system and the pathophysiology of schizophrenia
25. What are the functional consequences of neurocognitive deficits in schizophrenia?
26. Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders
27. Regional brain function in schizophrenia
28. The neuropathology of schizophrenia. A critical review of the data and their interpretation
29. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
30. Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study
31. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia
32. Properties of entorhinal cortex projection cells to the hippocampal formation
33. Brain metabolism patterns are sensitive to attentional effort associated with a tone recognition task
34. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task
35. Gross and histological criteria for developmental disorders in brains of schizophrenics
36. Hippocampal pathologic findings in schizophrenia. A morphometric study
37. 2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
38. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia
39. Ketamine activates psychosis and alters limbic blood flow in schizophrenia
40. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: A [3H]NGD-94-1 study
41. Plasticity at hippocampal to prefrontal cortex synapses: Dual roles in working memory and consolidation
42. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
43. Hippocampal-neocortical interaction: A hierarchy of associativity
44. Segregation of working memory functions within the dorsolateral prefrontal cortex
45. Patterns of cerebral blood flow in schizophrenia
46. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600
47. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex, and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia
48. Functions of neuronal networks in the hippocampus and neocortex in memory
49. Memory systems in the brain
50. Hippocampo-cortical and cortico-cortical backprojections
51. Implicit memory: A selective review
52. Disorientation of the hippocampal pyramidal cell and its processes in schizophrenic patients
53. Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia
54. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans
55. The neurophysiology of memory
56. Neuropsychiatric aspects of schizophrenia
57. Principles of the pharmacotherapy of schizophrenia
58. Enhancement of NMDA-mediated transmission in schizophrenia: Effects of milacemide
59. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains
60. Some connections of the entorhinal (area 28) and perihinal (area 35) cortices of the rhesus monkey. I. Temporal lobe afferents
61. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. III. Efferent connections
62. Some connections of the entorhinal (area 28) and perihinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents
63. Hippocampal function and schizophrenia. Experimental psychological evidence
64. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration
65. The hippocampus in schizophrenia: Lateralized increase in neuronal density and altered cytoarchitectural asymmetry